UBS Group AG

Position in PBE — Invesco Biotechnology & Genome ETF

CIK 1610520 ZURICH, V8

All Filings in PBE

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31 PBE	$5,461,518	68,976	+2.4%	Shares	Defined	2026-05-05
2025-12-31 PBE	$5,533,706	67,361	-6.5%	Shares	Defined	2026-01-29
2025-09-30 PBE	$5,032,386	72,025	-5.2%	Shares	Defined	2025-11-13
2025-06-30 PBE	$4,870,509	75,983	+3.8%	Shares	Defined	2025-08-14
2025-03-31 PBE	$4,645,710	73,230	-3.2%	Shares	Defined	2025-05-13
2024-12-31 PBE	$5,034,724	75,676	-4.8%	Shares	Sole	2025-02-14
2024-09-30 PBE	$5,548,036	79,462	+4.6%	Shares	Defined	2024-11-14
2024-06-30 PBE	$4,921,930	75,944	-12.8%	Shares	Sole	2024-08-14
2024-03-31 PBE	$5,634,587	87,061	+13.1%	Shares	Defined	2024-05-13
2023-12-31 PBE	$5,066,848	76,957	-18.3%	Shares	Defined	2024-02-09
2023-09-30 PBE	$5,376,019	94,250	+9.6%	Shares	Defined	2023-11-09
2023-06-30 PBE	$5,269,958	85,984	+0.6%	Shares	Defined	2023-08-11
2023-03-31 PBE	$5,364,135	85,457	-3.7%	Shares	Defined	2023-05-12
2022-12-31 PBE	$5,637,212	88,775	+3.6%	Shares	Defined	2023-02-08
2022-09-30 PBE	$5,051,452	85,705	-5.7%	Shares	Defined	2022-11-10
2022-06-30 PBE	$5,248,334	90,896	+238.1%	Shares	Defined	2022-08-10
2022-03-31 PBE	$1,667,427	26,881	-7.9%	Shares	Defined	2022-05-16
2021-12-31 PBE	$2,077,835	29,179	-2.3%	Shares	Defined	2022-02-14
2021-09-30 PBE	$2,235,619	29,872	+0.2%	Shares	Defined	2021-11-15
2021-06-30 PBE	$2,304,819	29,805	+5.6%	Shares	Defined	2021-08-13
2021-03-31 PBE	$2,084,455	28,237	-5.0%	Shares	Defined	2021-05-12
2020-12-31 PBE	$2,083,421	29,708	-3.0%	Shares	Defined	2021-02-11
2020-09-30 PBE	$1,733,930	30,624	-52.4%	Shares	Defined	2020-11-12
2020-06-30 PBE	$3,750,606	64,366	-0.3%	Shares	Defined	2020-07-31
2020-03-31 PBE	$2,999,952	64,529	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.